Zhanel G G, Harding G K, Nicolle L E
Department of Medicine, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.
Rev Infect Dis. 1991 Jan-Feb;13(1):150-4. doi: 10.1093/clinids/12.5.150.
This review analyzes several aspects of asymptomatic bacteriuria in patients with diabetes mellitus, including prevalence, bacteriology, coexistent risk factors, localization, natural history, and treatment. The prevalence of asymptomatic bacteriuria is threefold higher among diabetic women than among nondiabetic women. However, rates among diabetic and nondiabetic men are similar. Studies consistently document that the prevalence of asymptomatic bacteriuria is not influenced by the type or duration of diabetes or by the quality of diabetic control. The microorganisms causing asymptomatic bacteriuria in persons with diabetes mellitus are similar to those causing bacteriuria in nondiabetic individuals. More than half of diabetic patients with asymptomatic bacteriuria have upper urinary tract involvement. The long-term consequences of asymptomatic bacteriuria in patients with diabetes mellitus are poorly documented. Clinical trials describing the treatment of asymptomatic bacteriuria in this population suggest that a 2-week course of therapy is equivalent to a 6-week course for the initial eradication of bacteriuria and that, following treatment, reinfection rather than relapse usually occurs. Important questions remaining include whether asymptomatic bacteriuria should be treated in this population and what the optimal antimicrobial regimen is.
本综述分析了糖尿病患者无症状菌尿的几个方面,包括患病率、细菌学、共存危险因素、感染部位、自然史和治疗。糖尿病女性无症状菌尿的患病率是非糖尿病女性的三倍。然而,糖尿病男性和非糖尿病男性的患病率相似。研究一致表明,无症状菌尿的患病率不受糖尿病类型、病程或血糖控制质量的影响。糖尿病患者无症状菌尿的病原菌与非糖尿病个体菌尿的病原菌相似。超过一半的糖尿病无症状菌尿患者有上尿路受累。糖尿病患者无症状菌尿的长期后果记录较少。描述该人群无症状菌尿治疗的临床试验表明,为期2周的疗程与6周疗程在初始根除菌尿方面效果相当,且治疗后通常发生再感染而非复发。仍存在的重要问题包括该人群无症状菌尿是否应接受治疗以及最佳抗菌方案是什么。